PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.94%
Revenue growth above 1.5x CX's 13.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
19.94%
Gross profit growth at 75-90% of CX's 23.58%. Bill Ackman would demand operational improvements to match competitor gains.
-363.75%
Negative EBIT growth while CX is at 89.85%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-363.75%
Negative operating income growth while CX is at 70.77%. Joel Greenblatt would press for urgent turnaround measures.
19.11%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
-100.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-100.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-100.00%
Share reduction while CX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-100.00%
Reduced diluted shares while CX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y revenue/share CAGR while CX stands at 9.37%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while CX stands at 58.59%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative equity/share CAGR over 10 years while CX stands at 52.73%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-100.00%
Negative 5Y equity/share growth while CX is at 69.54%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-100.00%
Negative 3Y equity/share growth while CX is at 32.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.